Literature DB >> 7388740

Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum.

R M Olson, N P Perencevich, A W Malcolm, J T Chaffey, R E Wilson.   

Abstract

This study explores the patterns of recurrence after "curative" operation for colorectal cancer. For an 11-year period, 1960-1971, 281 evaluable patients were resected at the Peter Bent Brigham Hospital. Crude five-year survival in these patients was 49%, but only 10% of those with recurrence lived five years. A total of 69 patients relapsed during their lifetime and 34 additional patients were found to have metastases at death. The initial site of metastases were regional in 23 patients (33%) and distant in 32 (46%). Simultaneous regional and distant metastases were found in 13 (19%) for a total of 65% of patients having initial distant metastases. Approximate recurrence rates by site were: 30% for sigmoid and rectum, 20% for right colon, and 10% for transverse and left colon. Tumor size was a significant determinant of recurrence but did not select for regional or distant sites. Recurrence by Astler-Coller modification of the Dukes-Kirklin classification revealed 10% for A + B1, 33% for B2, 35% for C1, and 50% for C2. More than half of the patients with distant metastases (18/32) had solely hepatic metastases yet the total incidence of liver metastases as the initial site was only 8% of the total. In general, the site of the primary cancer was the most important determinant of the type of recurrence; the stage and site of the primary tumor were most predictive for eventual relapse.

Entities:  

Mesh:

Year:  1980        PMID: 7388740     DOI: 10.1002/1097-0142(19800615)45:12<2969::aid-cncr2820451214>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  55 in total

1.  Molecular staging estimates occult tumor burden in colorectal cancer.

Authors:  Alex Mejia; Stephanie Schulz; Terry Hyslop; David S Weinberg; Scott A Waldman
Journal:  Adv Clin Chem       Date:  2010       Impact factor: 5.394

2.  Local recurrence of rectosigmoid cancer: what about the choice of MRI for diagnosis?

Authors:  L Balzarini; E Ceglia; G D'Ippolito; R Petrillo; J D Tess; R Musumeci
Journal:  Gastrointest Radiol       Date:  1990

3.  Metastatic recurrence of early-stage colorectal cancer is linked to loss of heterozygosity on chromosomes 4 and 14q.

Authors:  F Al-Mulla; S AlFadhli; A H Al-Hakim; J J Going; M S Bitar
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

4.  A prospective study of six methods for detection of hepatic colorectal metastases.

Authors:  R Carter; D Hemingway; T G Cooke; R Pickard; F W Poon; J A McKillop; C S McArdle
Journal:  Ann R Coll Surg Engl       Date:  1996-01       Impact factor: 1.891

5.  The relationship between tumour volume and the extent of spread in colorectal carcinoma.

Authors:  K W Scott; R H Grace
Journal:  Int J Colorectal Dis       Date:  1994       Impact factor: 2.571

6.  Absence of a relationship of size of primary colon carcinoma with metastasis and survival.

Authors:  W Miller; D Ota; G Giacco; V Guinee; T Irimura; G Nicolson; K Cleary
Journal:  Clin Exp Metastasis       Date:  1985 Jul-Sep       Impact factor: 5.150

7.  Colorectal carcinoma in patients under age 40.

Authors:  A Behbehani; M Sakwa; R Ehrlichman; P Maguire; S Friedman; G D Steele; R E Wilson
Journal:  Ann Surg       Date:  1985-11       Impact factor: 12.969

8.  Predictors of successful salvage surgery for local pelvic recurrence of rectosigmoid colon and rectal cancers.

Authors:  Akihiko Kobayashi; Masanori Sugito; Masaaki Ito; Norio Saito
Journal:  Surg Today       Date:  2007-09-26       Impact factor: 2.549

9.  Surgical management of locally advanced and locally recurrent colon cancer.

Authors:  Ron G Landmann; Martin R Weiser
Journal:  Clin Colon Rectal Surg       Date:  2005-08

10.  Follow-up recommendations for colon cancer.

Authors:  W Donald Buie; Jo-Anne P Attard
Journal:  Clin Colon Rectal Surg       Date:  2005-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.